Shopping Cart
Remove All
Your shopping cart is currently empty
Labetuzumab
Copy Product Info
😃Good
Catalog No. T9901A-004Cas No. 219649-07-7
Alias IMMU-14, IMMU-100, hMN-14
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
Labetuzumab
Copy Product Info😃Good
Catalog No. T9901A-004Alias IMMU-14, IMMU-100, hMN-14Cas No. 219649-07-7
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $347 | - | In Stock | |
| 2 mg | $476 | - | In Stock | |
| 5 mg | $695 | - | In Stock | |
| 10 mg | $1,090 | - | In Stock | |
| 25 mg | $1,660 | - | In Stock | |
| 50 mg | $2,230 | - | In Stock | |
| 100 mg | $2,950 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:95.2% (SDS-PAGE); 95.6% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC). |
| In vivo | In vivo, Labetuzumab inhibits tumor growth following a single intravenous administration at a dose of 0.5 mg per rat [1]. |
| Synonyms | IMMU-14, IMMU-100, hMN-14 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CEACAM5 Protein (His) (TMPY-01647) at 1 μg/mL (100 μL/well) can bind Labetuzumab. The EC50 is 10.180 ng/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CEACAM5/CEA/CD66e |
| Molecular Weight | 145.1 kDa |
| Cas No. | 219649-07-7 |
| Relative Density. | no data available |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Labetuzumab | purchase Labetuzumab | Labetuzumab cost | order Labetuzumab | Labetuzumab chemical structure | Labetuzumab in vivo | Labetuzumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.